3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
14
Leukemia, Myeloid, Acute
7
Neoplasms
3
Neoplasm Metastasis
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Neuroblastoma
2
Liver Neoplasms
2
Hepatoblastoma
2
Fibrolamellar hepatocellular carcinoma
2
Tongue Neoplasms
1
Thyroid cancer, Hurthle cell
1
Thyroid Diseases
1
Sarcoma, Myeloid
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
1
Melanoma
1
Gastrointestinal Stromal Tumors
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Cisplatin
6
pembrolizumab
5
Nivolumab
5
palbociclib
4
durvalumab
4
Pemetrexed
4
atezolizumab
3
abemaciclib
3
Fulvestrant
3
Carboplatin
3
Anastrozole
3
130-nm albumin-bound paclitaxel
3
selpercatinib
2
ribociclib
2
relatlimab
2
entrectinib
2
cobimetinib
2
capmatinib
2
alectinib
2
Vemurafenib
2
Radiosurgery
2
Paclitaxel
2
Letrozole
2
Gonadotropin-Releasing Hormone
2
Gemcitabine
2
Bevacizumab
2
AZD9833
2
trametinib
1
taletrectinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Sorafenib
×
1 year
×
Clear all
No trials found.